MiniMed Group (MMED) Financials: Revenue & Earnings
MMED$19.23+0.30 +1.60%
$5.41B
Market Cap
-14.62
P/E
27.49
Forward P/E
58
Score
MiniMed Group (MMED) Financials: Revenue & Earnings
MMED price $19.23 +0.30 +1.60%
- Ticker
- MMED
- Price
- $19.23
- Change
- +0.30 +1.60%
- Market cap ?
- $5.41B
- P/E ?
- -14.62
- Forward P/E ?
- 27.49
- Dividend yield ?
- 0.00%
- Beta ?
- -3.71
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- Stocklytics score
- 58
- Value
- 35
- Quality
- 45
- Growth
- 94
Stocklytics score rationale: value 35, quality 45, growth 94.
Financials
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| 2245000000 | 2469000000 | 2715000000 | 3102000000 |
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable…
Fair value
MMED fair value $33.47. Price $19.23. Price is 43% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 504.34M. Growth 10.87%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.00%. Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 281.35M. Net debt -153.00M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-12-30 | — | 0.12 | — | 825.20M |
| 2026-09-01 | 0.12 | 0.12 | 843.00M | 826.80M |
| 2026-06-03 | -0.68 | -0.15 | 837.00M | 828.61M |
| 2026-04-17 | -0.16 | 0.17 | 790.00M | 789.48M |
Dividends
Yield 0.00%. Payout ratio —. Frequency —.
Safety score 24/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-15 | Lofton Kevin E | Buy | 836 | — | — |
| 2026-10-15 | Dianaty Ali | Buy | 11.11K | — | — |
| 2026-10-15 | Chandrasena Gillian | Buy | 1.80K | — | — |
| 2026-10-15 | Hopkins Robert (Bob) | Buy | 11.88K | — | — |
| 2026-10-15 | Endicott David J. | Buy | 3.37K | — | — |
| 2026-10-15 | Bricker Amy | Buy | 11.88K | — | — |
| 2026-10-15 | Bricker Amy | Other | 0 | — | — |
| 2026-10-15 | Medtronic plc | Sell | 252.81M | — | — |
| 2026-10-09 | Wicks Timothy A | Buy | 11.79K | — | — |
| 2026-10-09 | Lofton Kevin E | Buy | 11.79K | — | — |
| 2026-10-09 | GROSSMAN D KEITH | Buy | 11.79K | — | — |
| 2026-10-09 | Endicott David J. | Buy | 11.79K | — | — |
| 2026-10-09 | EISENBERG GLENN A | Buy | 11.79K | — | — |
| 2026-10-09 | Wicks Timothy A | Buy | 11.79K | — | — |
| 2026-10-09 | Lofton Kevin E | Buy | 11.79K | — | — |
| 2026-10-09 | GROSSMAN D KEITH | Buy | 11.79K | — | — |
| 2026-10-09 | Endicott David J. | Buy | 11.79K | — | — |
| 2026-10-09 | EISENBERG GLENN A | Buy | 11.79K | — | — |
| 2026-10-01 | Denton Sheila A. | Buy | 58.94K | — | — |
| 2026-09-25 | Denton Sheila A. | Other | 0 | — | — |
| 2026-07-31 | Wills Courtney Nelson | Sell | 1.76K | $18.15 | 31.98K |
| 2026-07-31 | Dianaty Ali | Sell | 8.01K | $18.15 | 145.42K |
| 2026-07-31 | Dallara Que | Sell | 31.35K | $18.15 | 569.00K |
| 2026-07-28 | Spooner Chad | Sell | 23.30K | $17.67 | 411.73K |
| 2026-07-28 | Chandrasena Gillian | Sell | 2.10K | $17.67 | 37.09K |
| 2026-07-03 | Cundy Scott T | Other | 0 | — | — |
| 2026-07-01 | Wills Courtney Nelson | Buy | 22.06K | — | — |
| 2026-07-01 | Wills Courtney Nelson | Buy | 60.73K | — | — |
| 2026-07-01 | Gyurci John | Buy | 24.24K | — | — |
| 2026-07-01 | Chandrasena Gillian | Buy | 14.71K | — | — |
| 2026-07-01 | Chandrasena Gillian | Buy | 29.48K | — | — |
| 2026-07-01 | Spooner Chad | Buy | 22.06K | — | — |
| 2026-07-01 | Spooner Chad | Buy | 94.55K | — | — |
| 2026-07-01 | Dianaty Ali | Buy | 36.76K | — | — |
| 2026-07-01 | Dianaty Ali | Buy | 94.55K | — | — |
| 2026-07-01 | Dallara Que | Buy | 297.62K | — | — |
| 2026-06-29 | Endicott David J. | Other | 0 | — | — |
| 2026-06-29 | Burman Linnea | Other | 0 | — | — |
| 2026-03-25 | Dallara Que | Sell | 4.81K | $16.31 | 78.43K |
| 2026-03-11 | Gyurci John | Buy | 15.32K | — | — |
| 2026-03-11 | Chandrasena Gillian | Buy | 58.83K | — | — |
| 2026-03-11 | Chandrasena Gillian | Buy | 28.12K | — | — |
| 2026-03-11 | Chandrasena Gillian | Buy | 19.85K | — | — |
| 2026-03-11 | Chandrasena Gillian | Buy | 11.49K | — | — |
| 2026-03-11 | Wills Courtney Nelson | Buy | 18.08K | — | — |
| 2026-03-11 | Wills Courtney Nelson | Buy | 13.65K | — | — |
| 2026-03-11 | Wills Courtney Nelson | Buy | 11.49K | — | — |
| 2026-03-11 | Wills Courtney Nelson | Buy | 5.74K | — | — |
| 2026-03-11 | Wills Courtney Nelson | Buy | 5.15K | — | — |
| 2026-03-11 | Wills Courtney Nelson | Buy | 955 | — | — |
| 2026-03-11 | Dianaty Ali | Buy | 46.99K | — | — |
| 2026-03-11 | Dianaty Ali | Buy | 35.45K | — | — |
| 2026-03-11 | Dianaty Ali | Buy | 33.68K | — | — |
| 2026-03-11 | Dianaty Ali | Buy | 14.63K | — | — |
| 2026-03-11 | Dianaty Ali | Buy | 11.56K | — | — |
| 2026-03-11 | Dianaty Ali | Buy | 11.05K | — | — |
| 2026-03-11 | Dianaty Ali | Buy | 2.44K | — | — |
| 2026-03-11 | Spooner Chad | Buy | 127.61K | — | — |
| 2026-03-11 | Spooner Chad | Buy | 70.90K | — | — |
| 2026-03-11 | Dallara Que | Buy | 281.94K | — | — |
| 2026-03-11 | Dallara Que | Buy | 127.61K | — | — |
| 2026-03-11 | Dallara Que | Buy | 80.84K | — | — |
| 2026-03-11 | Dallara Que | Buy | 57.24K | — | — |
| 2026-03-11 | Dallara Que | Buy | 51.04K | — | — |
| 2026-03-11 | Dallara Que | Buy | 22.89K | — | — |
| 2026-03-09 | Wicks Timothy A | Buy | 13.89K | — | — |
| 2026-03-09 | GROSSMAN D KEITH | Buy | 13.89K | — | — |
| 2026-03-09 | EISENBERG GLENN A | Buy | 13.89K | — | — |
| 2026-03-09 | Lofton Kevin E | Buy | 27.78K | — | — |
| 2026-03-09 | Gyurci John | Buy | 25.25K | $18.00 | 454.55K |
| 2026-03-09 | Gyurci John | Buy | 2.78K | — | — |
| 2026-03-09 | Chandrasena Gillian | Buy | 63.13K | $18.00 | 1.14M |
| 2026-03-09 | Chandrasena Gillian | Buy | 6.95K | — | — |
| 2026-03-09 | Wills Courtney Nelson | Buy | 63.13K | $18.00 | 1.14M |
| 2026-03-09 | Wills Courtney Nelson | Buy | 6.95K | — | — |
| 2026-03-09 | Dianaty Ali | Buy | 126.26K | $18.00 | 2.27M |
| 2026-03-09 | Dianaty Ali | Buy | 13.89K | — | — |
| 2026-03-09 | Spooner Chad | Buy | 84.18K | $18.00 | 1.52M |
| 2026-03-09 | Spooner Chad | Buy | 27.78K | — | — |
| 2026-03-09 | Dallara Que | Buy | 252.53K | $18.00 | 4.55M |
| 2026-03-09 | Dallara Que | Buy | 83.33K | — | — |
| 2026-03-06 | Wall Brett A. | Other | 0 | — | — |
| 2026-03-06 | Walter Matthew R. | Other | 0 | — | — |
| 2026-03-06 | Mauri Laura | Other | 0 | — | — |
| 2026-03-06 | Wicks Timothy A | Other | 0 | — | — |
| 2026-03-06 | Hopkins Robert (Bob) | Other | 0 | — | — |
| 2026-03-06 | GROSSMAN D KEITH | Other | 0 | — | — |
| 2026-03-06 | EISENBERG GLENN A | Other | 0 | — | — |
| 2026-03-06 | Lofton Kevin E | Other | 0 | — | — |
| 2026-03-06 | Gyurci John | Other | 0 | — | — |
| 2026-03-06 | Chandrasena Gillian | Other | 0 | — | — |
| 2026-03-06 | Wills Courtney Nelson | Other | 0 | — | — |
| 2026-03-06 | Dianaty Ali | Other | 0 | — | — |
| 2026-03-06 | Spooner Chad | Other | 0 | — | — |
| 2026-03-06 | Dallara Que | Other | 0 | — | — |
| 2026-03-05 | Eso Christopher | Other | 0 | — | — |
| 2026-03-05 | Sandstrom Brian | Other | 0 | — | — |
| 2026-03-05 | Medtronic plc | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 105, holders +45 vs prior quarter. Ownership 13.98%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 8.33M | 1.46M | +21.17% | 124.60M |
| MILLENNIUM MANAGEMENT LLC | 3.06M | 467.18K | +18.01% | 45.76M |
| CITADEL ADVISORS LLC | 2.87M | 2.85M | +25951.85% | 42.84M |
| LONGAEVA PARTNERS L.P. | 2.81M | -365.68K | -11.50% | 42.05M |
| SESSA CAPITAL IM, L.P. | 2.00M | 0 | 0.00% | 29.90M |
| BLACKROCK, INC. | 2.00M | 1.97M | +7527.47% | 29.85M |
| NORGES BANK | 1.96M | 1.96M | New | 29.32M |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 1.52M | 465.00K | +44.08% | 22.72M |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 1.44M | 1.03M | +251.15% | 21.48M |
| FMR LLC | 1.08M | -284.31K | -20.83% | 16.16M |
| GEODE CAPITAL MANAGEMENT, LLC | 956.02K | 710.09K | +288.74% | 14.30M |
| BOSTON PARTNERS | 902.36K | 57.36K | +6.79% | 13.50M |
| J. GOLDMAN & CO LP | 830.22K | 830.22K | New | 12.41M |
| NUVEEN, LLC | 539.31K | 539.31K | New | 8.06M |
| UBS GROUP AG | 413.42K | 102.07K | +32.78% | 6.18M |
| STATE STREET CORP | 403.29K | 403.29K | New | 6.03M |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 375.00K | -375.00K | -50.00% | 5.61M |
| FIRST TRUST ADVISORS LP | 366.27K | 267.12K | +269.41% | 5.48M |
| VANGUARD CAPITAL MANAGEMENT LLC | 323.32K | 323.32K | New | 4.83M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 300.00K | 300.00K | New | 4.49M |
| BURKEHILL GLOBAL MANAGEMENT, LP | 300.00K | 0 | 0.00% | 4.49M |
| READYSTATE ASSET MANAGEMENT LP | 294.28K | -20.72K | -6.58% | 4.40M |
| NEUBERGER BERMAN GROUP LLC | 264.67K | 264.67K | New | 3.96M |
| TUDOR INVESTMENT CORP ET AL | 258.21K | 242.31K | +1523.99% | 3.86M |
| ALBERTA INVESTMENT MANAGEMENT CORP | 250.00K | 0 | 0.00% | 3.74M |
Earnings and financials
MiniMed Group, Inc. (MMED) trades at $19.23, with a market cap of $5.41B and a trailing P/E of -14.62. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| 2245000000 | 2469000000 | 2715000000 | 3102000000 |
Insights · Dividends · Forecast · Financials · Learn